Beijing Breathgreen

Beijing Breathgreen is a specialized pharmaceutical company focused on the respiratory, ENT, and pediatric therapeutic areas in China. Established in 2013, the company functions as a full-service commercialization platform, partnering with international pharmaceutical firms to introduce and scale innovative treatments within the Chinese market. Its product portfolio includes a range of inhaled corticosteroids, nasal sprays, and anti-infectives designed to treat chronic airway diseases and inflammatory conditions. Breathgreen integrates research and development with a robust clinical promotion and sales network that spans thousands of medical institutions. The company is backed by prominent investors such as Legend Capital and Matrix Partners China, positioning it as a key player in the domestic respiratory medicine sector.